This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1993 Jun 21:681:594-602.

doi: 10.1111/j.1749-6632.1993.tb22951.x.

Immunosuppressive treatments. Their efficacy on myasthenia gravis patients' outcome and on the natural course of the disease

F Cornelio¹, C Antozzi, R Mantegazza, P Confalonieri, E Berta, D Peluchetti, A Sghirlanzoni, F Fiacchino

Affiliations

PMID: 8357208
DOI: 10.1111/j.1749-6632.1993.tb22951.x

Immunosuppressive treatments. Their efficacy on myasthenia gravis patients' outcome and on the natural course of the disease

F Cornelio et al. Ann N Y Acad Sci. 1993.

. 1993 Jun 21:681:594-602.

doi: 10.1111/j.1749-6632.1993.tb22951.x.

Authors

F Cornelio¹, C Antozzi, R Mantegazza, P Confalonieri, E Berta, D Peluchetti, A Sghirlanzoni, F Fiacchino

Affiliation

¹ Neuromuscular Research Center, Istituto Nazionale Neurologico C. Besta, Milan, Italy.

PMID: 8357208
DOI: 10.1111/j.1749-6632.1993.tb22951.x

No abstract available

PubMed Disclaimer

Similar articles

The role of plasma exchange in treatment of myasthenia gravis.
Dau PC. Dau PC. Prog Clin Biol Res. 1982;106:143-56. Prog Clin Biol Res. 1982. PMID: 7178136 No abstract available.
Current treatment of myasthenia gravis.
Osterman PO. Osterman PO. Prog Brain Res. 1990;84:151-61. doi: 10.1016/s0079-6123(08)60899-7. Prog Brain Res. 1990. PMID: 2267293 Review. No abstract available.
[Therapy of myasthenia gravis].
Henze T. Henze T. Dtsch Med Wochenschr. 1986 Mar 28;111(13):507-9. doi: 10.1055/s-2008-1068481. Dtsch Med Wochenschr. 1986. PMID: 3956394 German. No abstract available.
Immunopharmacological treatment in myasthenia gravis.
Nyberg-Hansen R, Gjerstad L. Nyberg-Hansen R, et al. Transplant Proc. 1988 Jun;20(3 Suppl 4):201-10. Transplant Proc. 1988. PMID: 3289206 Review. No abstract available.
The course of myasthenia gravis in patients treated with corticosteroids, azathioprine, and plasmapheresis.
Cornelio F, Peluchetti D, Mantegazza R, Sghirlanzoni A, Collarile C. Cornelio F, et al. Ann N Y Acad Sci. 1987;505:517-25. doi: 10.1111/j.1749-6632.1987.tb51320.x. Ann N Y Acad Sci. 1987. PMID: 3479934 No abstract available.

See all similar articles

Cited by

Plasma exchange for myasthenia gravis.
Gajdos P, Chevret S, Toyka K. Gajdos P, et al. Cochrane Database Syst Rev. 2002;2002(4):CD002275. doi: 10.1002/14651858.CD002275. Cochrane Database Syst Rev. 2002. PMID: 12519572 Free PMC article.
Intravenous immunoglobulin treatment in neurological diseases.
Otten A, Vermeulen M, Bossuyt PM, Otten A. Otten A, et al. J Neurol Neurosurg Psychiatry. 1996 Apr;60(4):359-61. doi: 10.1136/jnnp.60.4.359. J Neurol Neurosurg Psychiatry. 1996. PMID: 8774395 Free PMC article. Review. No abstract available.
Myasthenia gravis as a prototype autoimmune receptor disease.
Hoedemaekers AC, van Breda Vriesman PJ, De Baets MH. Hoedemaekers AC, et al. Immunol Res. 1997;16(4):341-54. doi: 10.1007/BF02786398. Immunol Res. 1997. PMID: 9439759 Review.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Wiley
Medical
- MedlinePlus Health Information